Evaluation of GSK Biologicals' dTpa Booster Vaccine in Young Adults 10 Years After Previous dTpa Boosting.
Phase of Trial: Phase IV
Latest Information Update: 08 Jun 2018
At a glance
- Drugs DTaP vaccine (Primary)
- Indications Diphtheria; Pertussis; Tetanus
- Focus Pharmacodynamics
- Sponsors GlaxoSmithKline
- 22 Jan 2009 Planned number of patients changed from 509 to 82 as reported by ClinicalTrials.gov.
- 20 May 2008 The expected completion date for this trial is now 1 Apr 2008.
- 16 May 2008 Status changed from in progress to completed.